GMO strengthens equities line-up
Global investment management firm GMO has appointed three senior investment professionals to its Sydney-based Australian equities team.
Geoff Wells, Mark Thompson and Bradley Grehan are intended to “strengthen GMO’s global portfolio management, research and trading efforts”, according to GMO’s head of Australian equities Rick Suvak.
Formerly a senior portfolio manager at Macquarie Investment Management, Wells has been appointed as a senior quantitative research analyst, focusing primarily on alpha model research.
Thompson has also joined GMO as senior quantitative research analyst, and will also be concentrating on alpha model research.
He was previously a quantitative portfolio manager at State Street Global Advisors where he managed the group’s short enabled strategies (market-neutral, equitised long-short and 130/30 portfolios).
Grehan joins GMO as a senior portfolio trader, and will focus on trade execution while also participating in the management of GMO’s Australian equity portfolios.
He brings 12 years of industry and trading experience to GMO from Tolhurst, Morgan Stanley and JBWere.
Recommended for you
Funds under management at Pinnacle Investment Management are approaching $180 billion, helped by a substantial jump in FUM from its overseas affiliates.
Warakirri Asset Management has partnered with US-based investment manager ClariVest to give Australian retail and wholesale investors access to the firm’s global small companies strategy.
Global X has come out fighting in the race to the bottom for ETF fees with an Australian equity ETF offering fees of just 0.04 per cent per annum, less than half those of the $20 billion Vanguard Australian Shares Index ETF.
Betashares has expanded its equity range, launching its latest Australian equity ETF and reducing the management fee on its existing global dividend ETF.
